{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:16:55Z","timestamp":1791433015359,"version":"4.3.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803874"],"award-info":[{"award-number":["81803874"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872494"],"award-info":[{"award-number":["81872494"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873042"],"award-info":[{"award-number":["81873042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074063"],"award-info":[{"award-number":["82074063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ymthe.2022.01.007","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T03:03:21Z","timestamp":1641524601000},"page":"1188-1200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment"],"prefix":"10.1016","volume":"30","author":[{"given":"Quanjun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuier","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2022.01.007_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T\u00a0cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.01.007_bib2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S1470-2045(19)30641-2","article-title":"Quality of life and CAR-T cell therapy in children, adolescents, and young adults with haematological malignancies","volume":"20","author":"Efficace","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.cell.2018.03.038","article-title":"Universal chimeric antigen receptors for multiplexed and logical control of T\u00a0cell responses","volume":"173","author":"Cho","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.01.007_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T\u00a0cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.007_bib5","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.ymthe.2021.02.024","article-title":"Pre-conditioning modifies the TME to enhance solid tumor CAR T\u00a0cell efficacy and endogenous protective immunity","volume":"29","author":"Murad","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.01.007_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","article-title":"Intratumoral heterogeneity in cancer progression and response to immunotherapy","volume":"27","author":"Vitale","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.007_bib7","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.ymthe.2020.07.018","article-title":"IL-15 preconditioning augments CAR T\u00a0cell responses to checkpoint blockade for improved treatment of solid tumors","volume":"28","author":"Giuffrida","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.01.007_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","article-title":"Metabolic barriers to cancer immunotherapy","volume":"21","author":"DePeaux","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.01.007_bib10","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-12-1773","article-title":"IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives","volume":"18","author":"Yang","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2022.01.007_bib11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41591-018-0095-6","article-title":"Suppression of antitumor T\u00a0cell immunity by the oncometabolite (R)-2-hydroxyglutarate","volume":"24","author":"Bunse","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.01.007_bib12","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1158\/1078-0432.CCR-17-3855","article-title":"D-2-hydroxyglutarate is an intercellular mediator in IDH-mutant gliomas inhibiting complement and T\u00a0cells","volume":"24","author":"Zhang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2022.01.007_bib13","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1101\/gad.294991.116","article-title":"Mutant IDH1 regulates the tumor-associated immune system in gliomas","volume":"31","author":"Amankulor","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymthe.2022.01.007_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41581-019-0210-z","article-title":"Oncometabolites in renal cancer","volume":"16","author":"Yong","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/neuonc\/noy113","article-title":"2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data","volume":"20","author":"Suh","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/BLCTT.S177913","article-title":"IDH1-mutated relapsed or refractory AML: current challenges and future prospects","volume":"9","author":"Megias-Vericat","year":"2019","journal-title":"Blood Lymphat Cancer"},{"key":"10.1016\/j.ymthe.2022.01.007_bib17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1158\/1078-0432.CCR-20-2500","article-title":"Randomized phase II and biomarker study of pembrolizumab plus bevacizumab versus pembrolizumab alone for patients with recurrent glioblastoma","volume":"27","author":"Nayak","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2022.01.007_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nprot.2012.143","article-title":"Identification, isolation and in\u00a0vitro expansion of human and nonhuman primate T stem cell memory cells","volume":"8","author":"Lugli","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2022.01.007_bib19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.20161760","article-title":"Human memory CD8 T\u00a0cell effector potential is epigenetically preserved during in\u00a0vivo homeostasis","volume":"214","author":"Abdelsamed","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2022.01.007_bib20","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.immuni.2016.10.017","article-title":"Constitutive glycolytic metabolism supports CD8+ T\u00a0cell effector memory differentiation during viral infection","volume":"45","author":"Phan","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2022.01.007_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev-immunol-042617-053019","article-title":"Unraveling the complex interplay between T\u00a0cell metabolism and function","volume":"36","author":"Klein Geltink","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib22","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.4049\/jimmunol.0901766","article-title":"The optimal antigen response of chimeric antigen receptors harboring the CD3\u03b6 transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR\/CD3 complex","volume":"184","author":"Bridgeman","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10545-012-9462-5","article-title":"Progress in understanding 2-hydroxyglutaric acidurias","volume":"35","author":"Kranendijk","year":"2012","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2022.01.007_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8768","article-title":"D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2","volume":"6","author":"Lin","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.01.007_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.chembiol.2020.02.002","article-title":"MYC regulation of D2HGDH and L2HGDH influences the epigenome and epitranscriptome","volume":"27","author":"Qiu","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1134\/S0026893319060116","article-title":"Methods of evaluating the efficiency of CRISPR\/Cas genome editing","volume":"53","author":"Lomov","year":"2019","journal-title":"Mol. Biol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2017.12.025","article-title":"An integrated view of immunometabolism","volume":"172","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.01.007_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ymthe.2016.10.016","article-title":"Improving chimeric antigen receptor-modified T\u00a0cell function by reversing the immunosuppressive tumor microenvironment of pancreatic cancer","volume":"25","author":"Mohammed","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.01.007_bib29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41580-019-0123-5","article-title":"Metabolic regulation of cell growth and proliferation","volume":"20","author":"Zhu","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib30","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T\u00a0cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.01.007_bib31","doi-asserted-by":"crossref","first-page":"e1226","DOI":"10.1002\/cti2.1226","article-title":"Therapeutic strategies to remodel immunologically cold tumors","volume":"9","author":"Wang","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cmet.2015.07.020","article-title":"Mitochondrial respiration controls lysosomal function during inflammatory T\u00a0cell responses","volume":"22","author":"Baixauli","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2022.01.007_bib33","first-page":"1","article-title":"IDH1\/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction\u2014a retrospective propensity score analysis","volume":"35","author":"Kattih","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2022.01.007_bib34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.01.007_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.humpath.2018.04.014","article-title":"Non\u2013small cell lung cancers with isocitrate dehydrogenase 1 or 2 (IDH1\/2) mutations","volume":"78","author":"Toth","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ymthe.2022.01.007_bib37","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1158\/1078-0432.CCR-13-0017","article-title":"Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations","volume":"19","author":"Hartmann","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2022.01.007_bib38","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1158\/1078-0432.CCR-17-2796","article-title":"IDH1\/2 mutations sensitize acute myeloid leukemia to PARP inhibition and this is reversed by IDH1\/2-mutant inhibitors","volume":"24","author":"Molenaar","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2022.01.007_bib39","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ymthe.2018.01.022","article-title":"In\u00a0vivo expansion and antitumor activity of coinfused CD28- and 4-1BB-engineered CAR-T cells in patients with B cell leukemia","volume":"26","author":"Cheng","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.01.007_bib40","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.ymthe.2018.06.012","article-title":"CAR T\u00a0cells with enhanced sensitivity to B cell maturation antigen for the targeting of B cell non-Hodgkin\u2019s lymphoma and multiple myeloma","volume":"26","author":"Bluhm","year":"2018","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T18:46:04Z","timestamp":1716230764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001622000077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1525001622000077"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.007","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}